Enerzair Breezhaler

Enerzair Breezhaler Indications/Uses

Manufacturer:

Novartis

Distributor:

Zuellig Pharma

Marketer:

A. Menarini
Full Prescribing Info
Indications/Uses
Enerzair Breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta2-agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in